Impact of Baseline Clinical Variables on SGLT2i’s Antiproteinuric Effect in Diabetic Kidney Disease

Introduction: Proteinuria is a major risk factor for the progression of chronic kidney disease (CKD). Sodium-glucose cotransporter 2 inhibitors (SGLT2i) demonstrated a nephroprotective and antiproteinuric effect in people with type 2 diabetes (T2DM) and proteinuric CKD. We conducted a retrospective...

Полное описание

Библиографические подробности

Главные авторы:	Irene Capelli, Danilo Ribichini, Michele Provenzano, Daniele Vetrano, Valeria Aiello, Giuseppe Cianciolo, Valentina Vicennati, Alessandro Tomassetti, Ginevra Moschione, Sabrina Berti, Uberto Pagotto, Gaetano La Manna
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2023-04-01
Серии:	Life
Предметы:	sodium-glucose cotransporter 2 SGLT2 inhibitors proteinuria diabetes chronic kidney disease diabetic kidney disease
Online-ссылка:	https://www.mdpi.com/2075-1729/13/4/1061
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!